Nature's Sunshine Products (NATR) Tops Q3 EPS by 2c, provides outlook

Nature's Sunshine Products (NASDAQ: NATR) reported Q3 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $111.2 million versus the consensus estimate of $110.4 million.

Outlook

The Company expects full year 2023 net sales to range between $443 - $451 million and expects adjusted EBITDA to range between $37 - $40 million, compared to the original expected range of $34 - $38 million.

For earnings history and earnings-related data on Nature's Sunshine Products (NATR) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform